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Urea volume of distribution exceeds total body water in patients therapy for patients with acute renal failure (ARF) is
with acute renal failure. important in determining their outcome [7–9]. To guide
Background. An accurate estimate of volume of distribution the prescription of therapy and the quantification of de-of urea (Vurea) is critically important to guide the prescription
livered dialysis dose, most investigators to date haveof therapy and the quantification of delivered dialysis dose in
applied concepts of Kt/V (where K is the clearance ofpatients with chronic and acute renal failure (ARF). While
Vurea has been shown to be substantially the same as total body the dialyzer, t is time on dialysis, and V is volume of
water (TBW) in other patient populations, this relationship distribution of urea) using formulae derived from pa-
has not been adequately studied in detail in ARF patients.
tients with chronic renal failure by solving mass balanceMethods: To evaluate this question, we undertook a system-
equations. Although these formulae have not been spe-atic study of these parameters in a cohort of 28 patients with
ARF to analyze methods of estimating Vurea and TBW using cifically validated in patients with acute renal failure,
blood-based kinetic data, anthropometric data and bioelectri- at the present time they represent the best validated,
cal impedance analysis (BIA). clinically applicable approach to urea kinetic modeling
Results. The results show that Vurea estimated by double- in this patient population. In order to guide the prescrip-pool Kt/V (67.9  19.2 L) and by equilibrated Kt/V (61.2 
tion of therapy from blood-based urea kinetic modeling,13.6 L) were statistically significantly higher than Vurea deter-
mined by single-pool Kt/V (55.3  12.9 L; difference of 16% it is important to have an accurate estimate of the volume
and 11%, respectively). Determination of TBW by anthropo- of distribution of urea (Vurea). Accurate determinationmetric measurements (Watson, 42.5  7.0 L; Hume-Weyer, of Vurea is also important for comparing solute removal43.6 7.1 L; Chertow, 46.8 8.1 L) yielded significantly lower
in continuous versus intermittent forms of renal replace-measures compared to TBW determined by physiological for-
mulae and by BIA (51.1  11.6 L and 51.1  13.3 L, respec- ment therapy [10–14].
tively). Most importantly, all measures of Vurea by blood-based In addition to the need for measuring Vurea as a guide
kinetics exceeded TBW measurements by any method (7% to for renal replacement therapy, patients with acute renal
50% difference).
failure need to have an accurate assessment of total bodyConclusion. Our results suggest that in terms of useful guide-
water measured to guide appropriate drug dosing andlines to prescribe a specific dose of dialysis in patients with
acute renal failure, estimates of TBW cannot be used as a for achieving electrolyte and acid-base homeostasis. For
surrogate for Vurea in determining dialysis adequacy. practical reasons, Vurea is generally assumed to be equiva-
lent to total body water. Indeed, urea, as a low molecular
weight, non-polar, non-protein bound substance, is gen-
Increasing attention is being paid to quantification of erally felt to be freely diffusable across cell membranes,
urea removal in patients with acute renal failure who resulting in rapid equilibration with water space. Earlier
undergo renal replacement therapy [1–6]. Several recent studies in healthy individuals have shown that labeled
studies have suggested that the dose of renal replacement injected urea has a volume of distribution equal to total
body water [15]. While several readily clinically available
methodologies of estimating total body water are avail-Key words: hemodialysis, kinetics, dialysis dose, anthropomorphic
body water, acute renal failure, RRT, urea kinetic modeling. able, none have been systematically examined in patients
with acute renal failure since the 1970s [16–18]. Further-Received for publication March 12, 2001
more, to date, there are no systematic studies availableand in revised form August 12, 2001
Accepted for publication August 30, 2001 comparing clinically commonly used estimates of Vurea
and total body water in patients with acute renal failure. 2002 by the International Society of Nephrology
317
Himmelfarb et al: Volume of distribution of urea in ARF318
We have recently reported the results of systematic tored throughout the procedure; the blood pump speeds
were adjusted to maintain a venous pressure of less thanmeasurement of the dose of delivered dialysis using
available urea kinetic formulae in a cohort of patients 200 mm Hg and an arterial pressure of no less than
negative 200 mm Hg. At the end of the treatment, thewith acute renal failure receiving intermittent hemodial-
ysis [6]. Our current study utilized the same patient co- patient’s post-treatment weight was obtained, and the
actual dialysis time was recorded. The net volume re-hort to analyze methods of estimating Vurea and TBW
using blood-based kinetic data, anthropometric data and moved by ultrafiltration was recorded.
Blood sampling. Pretreatment blood urea nitrogenbioelectrical impedance analysis. We report that esti-
mates of Vurea by all available formulae exceed estimates (BUN) samples were obtained in all patients within 5 to
10 minutes prior to the initiation of the treatment. Toof total body water, suggesting that there may be discrep-
ancies between urea volume of distribution and water determine the in vivo dialyzer urea clearance during the
treatment, the afferent (Ci) and efferent (Co) dialyzerspace in patients with acute renal failure.
BUN levels were simultaneously drawn both at 15 min-
utes and 180 minutes following the initiation of treat-
METHODS
ment, and the blood pump speeds were recorded. A
Patient population post-treatment BUN was obtained at the end of each
treatment using the slow-flow method. Specifically, theFrom December 1, 1996, until April 30, 1997, all pa-
tients over the age of 18 who were treated with intermit- blood pump speed was decreased to 50 mL/min for two
minutes before the sample was obtained. For 34 of thetent HD (IHD) for ARF at the Vanderbilt University
Medical Center and the Maine Medical Center were 46 treatments, BUN levels were also obtained 30 minutes
after the completion of the dialysis treatment. All sam-eligible for inclusion in this study. The patients were
excluded from the study if they had a urine output of ples were analyzed in triplicate with a Beckman BUN
Analyzer 2 (Beckman Instruments, Fullerton, CA, USA)more than 400 mL/day, inadequate data acquisition or
treatment durations of less than three hours, generally utilizing urea plasma standards. For samples not ana-
lyzed within two hours of completing the treatment, thebecause of hemodynamic instability. The study was a
prospective, observational design and was approved by plasma was placed in a nonsterile polypropylene vial and
was stored at 70C.the institutional review board at both study centers; in-
formed consent was obtained for the HD procedure. Kinetic estimates of urea volume distribution. For each
treatment, several methods were used to quantify the doseData on solute removal from this patient cohort has
previously been reported [6]. of dialysis, based on the methodology used for CHD.
To determine the delivered dose of dialysis for each treat-
Hemodialysis treatment ment a single-pool Kt/V (spKt/V) and an equilibrated
Kt/V (eKt/V) were calculated by the Daugirdas II equa-All studied HD treatments were performed with a
Fresenius 2008E volumetric HD machine. All treatments tion and the Daugirdas rate equation, respectively [19].
A double-pool Kt/V (dpKt/V) was calculated by substi-were done with new biocompatible membranes (Frese-
nius F-80A or Toray B2-1.5H) that were not reused tuting the post-blood urea nitrogen (BUN) concentra-
tion in the Daugirdas II formula with the 30-minuteand used bicarbonate dialysate. All patients were dia-
lyzed via a percutaneous, dual-lumen, polyurethane dial- post-blood BUN concentration [19]. Once the dose was
determined, the volume of distribution was calculatedysis catheter (Quinton or VasCath) placed in a central
vein (femoral, internal jugular, or subclavian). using the measured dialyzer clearances measured during
the same treatment (15 and 180 min). All equations used
Study design in this study are listed in the Appendix.
Anthropometric estimates of total body water. Total bodyGeneral. All physician orders, including the initiation
and the timing of HD, were written by the renal fellows water was estimated using the Watson, Hume-Weyer,
Chertow [20] and physiologic formulae. The equationsand supervised by the attending nephrologists directly
caring for the patient. No change in patient care, includ- are listed in the Appendix.
Bioelectrical impedance analysis. Bioelectrical imped-ing the initiation of HD or the number of times dialyzed
per week, was done for study purposes. Prior to each HD ance analysis (BIA) was done using Quantum, BIA 101Q
(RJL Systems, Clifton Township, MI, USA). All teststreatment, the following prescription parameters were
obtained: the prescribed time, dialysate and blood flows, were done 30 minutes following termination of hemodi-
alysis. In brief, subjects were placed in a supine positionand the patient’s height and weight. To calculate the
delivered dose of dialysis, the blood and dialysate pump with their arms at but not touching their sides and with
their legs separated. Electrodes were attached to theirspeeds were recorded every 15 minutes, and the time-
averaged value was obtained and used in the subsequent right hand and foot and a high frequency, alternating
low voltage was passed across the limbs; the currentcalculations. Arterial and venous pressures were moni-
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Table 1. Patient demographics
Age 58.620.3
Male 65.515.0
Female 51.824.2
Gender male 15M (54%)
13F (46%)
White 23 (82%)
Weight kg
Male 85.011.5
Female 77.624.5
Height cm
Male 1786
Female 1598
Treatments per patient 1.610.88
Range of number of treatments 1–4
Fig. 1. Volume of distribution of urea by blood-side kinetics. Abbrevia-
tions are: spVurea, single pool urea volume of distribution; eVurea, equili-
brated urea volume of distribution; dpVurea, double pool urea volume
of distribution. *P  0.05 compared to spVurea.
passing through the body was measured. From this mea-
surement, reactance and resistance values were mea-
sured. Based on the measured whole-body electrical re- B2-1.5H dialyzer. Eighty percent of the patients were
sistance, total body water was calculated according to dialyzed three-times a week and 20% dialyzed every
predetermined regression equations [21, 22]. other day.
Statistical analysis
Kinetic determination of volume of
Demographic data and various treatment characteris- distribution of urea
tics were tabulated. Differences between the study vari-
We have previously reported the data on solute re-ables, for example the kinetic estimates of urea volume
moval from this patient cohort [6]. Using these Kt/Vof distribution and total body water estimates by anthro-
determinations based on blood-based kinetic formulae,pometric equations and BIA were evaluated by paired
we determined the urea volume of distribution (Fig. 1).t test (with Bonferroni correction) and one-way ANOVA.
The estimated volume of distribution of urea using singleThe percent differences between the blood-based volume
pool urea kinetics was 55.3  12.9 L. The volume of dis-determinations and anthropometric estimates were de-
tribution of urea determined both by equilibrated Kt/Vtermined. Univariate associations between study vari-
(eKt/V, 61.2  13.6) and double-pool Kt/V (dpKt/V,ables and the percent difference versus various patient
67.9  19.2) were both significantly higher than singleand treatment variables, such as, age, gender, weight, race,
pool-derived V (P  0.001 for both). The difference intype of dialyzer used, the center that the patient dialyzed
Vurea determined by eKt/V and dpKt/V were 11% andat (VUMC or MMC) and the use of anticoagulation (yes
16%, respectively, and were not significantly differentor no) were evaluated by a general linear model. Finally,
from each other. Since the kinetically derived determina-the data were analyzed according to Bland and Altman
tion of the volume of distribution of urea is dependentplots to assess the agreement in the blood-based volume
on in vivo dialyzer clearance, it was important to ascer-determinations and anthropometric estimates [23]. All
tain that in vivo dialyzer urea clearances were relativelytests of significance were two-sided, and differences were
constant throughout the dialysis treatment. The mean inconsidered statistically significant when the P value was
vivo urea clearances were 218.0  41.8 mL/min at 150.05. All data was expressed as means  SD. SAS
minutes and 218.0 52.2 mL/min at three hours, respec-version 8.2 was used for all analysis (SAS Institute, Cary,
tively (PNS), demonstrating that there was no declineNC, USA).
in dialyzer performance during the treatment session.
RESULTS Measurement of total body water
Patient demographics Figure 2 summarizes total body water as determined
by five different clinical methods. Total body water de-Forty-six treatments in 28 consecutively dialyzed pa-
terminations by the Watson formula (42.5  7.0 L) andtients had complete data and were used for further analy-
the Hume-Weyer formula (43.6 7.1 L) were not differ-sis. Table 1 summarizes the demographic data for the
ent from each other and both were significantly lowerstudy patients. Fifty-four percent of the studied patients
than TBW determined by the Chertow formula (46.8 were male and 82% were white. Twenty-eight (61%) of
8.1 L; P 0.001 vs. Watson and Hume-Weyer formulae).the treatments were performed with a Fresenius F-80A
dialyzer, while 18 (39%) were performed with a Toray Total body water determinations by physiologic formula
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Fig. 2. Estimates of total body water by anthropometric measurements.
*P  0.05 compared to Watson and Hume-Weyer formulae, §P  0.05
compared to Chertow formulae.
Table 2. Percent differences between anthropometric total body
water determinations and volume of distribution of urea by
blood-based kinetics
Fig. 3. Bland-Altman analysis of agreement between urea volume ofspVurea eVurea DpVurea
distribution derived from equilibrated Kt/V and estimates of total body
Watson 2726 4127 5028 water by weight (A) and bioelectrical impedance analysis (B).
Hume-Weyer 2426 3727 4828
Chertow 1624 2825 3725
BIA 1128 2331 2934
Post-HD wt 727 1829 2731
based on body weight and by bioelectrical impedance
analysis were not different from each other (51.1 11.6 L
and 51.1 13.3 L, respectively). All Hume-Weyer, Wat-
son and Chertow estimates of TBW were statistically
significantly lower than both TBW determined by bio-
electrical impedance and physiologic formulas based on
weight (P  0.001).
Comparison of Vurea and TBW
There were statistically significant correlations between
all estimated Vurea and TBW measurements. Determina-
tions of urea volume of distribution by all four formulae
were significantly higher than TBW determined by five
separate formulae (P  0.05 for all). Table 2 demon-
strates the percentage variance between formulas for
TBW and Vurea. The highest percentage difference was
observed between Watson formulae and dpVurea (differ-
ence of 50 28%), while TBW determination by weight
and BIA provided the closest estimations to spVurea (dif-
ference of 7  27% and 11  28%, respectively).
Bland-Altman analysis of the agreement between urea
volume of distribution by urea kinetic modeling (dpVurea
and eVurea) and those by total body water estimations
(BIA and weight) are depicted in Figures 3 and 4. Bland-
Fig. 4. Bland-Altman analysis of agreement between urea volume of
Altman analysis of the residual error indicated that the distribution derived from double-pool Kt/V and estimates of total body
water by weight (A) and bioelectrical impedance analysis (B).average difference between eVurea and TBW by BIA was
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9.7 12.3 L. The 95% confidence interval (two standard ments of TBW and Vurea in critically ill patients with
acute renal failure observed in this study may be thedeviation units) for this mean difference was between
2.6 L and 22 L. The slope of this line was not signifi- lack of complete equilibration for urea concentration in
all body spaces. Indeed, in patients with acute renal fail-cantly different from zero (0.15), demonstrating that the
differences were similar at low versus high body weights. ure, the likelihood of urea disequilibrium between per-
fused and non-perfused compartments is certainly higherSimilar analysis between dpVurea and TBW by BIA
showed an average difference of 13.4 14.3 L with 95% than in the setting of stable patients with chronic renal
failure. Problems related to hemodynamic instability asconfidence interval (two standard deviations) between
0.09 L and 27.7 L. The slope of this relationship was well as capillary leak syndromes may contribute to in-
creased compartmentalization of body fluids. Hyperca-also not significantly significant from zero (0.415).
tabolism, with resulting increased urea generation, also
Predictors of Vurea and total body water measurements may contribute to disequilibrium. It is conceivable that
urea concentrates intracellularly preferentially in pa-To determine the potential factors that may predict
TBW and Vurea by different techniques as well as factors tients with acute renal failure due to acquired defects
in urea transporter function and in diffusive capacity.that may account for the difference between TBW and
Vurea, we evaluated several patient and treatment vari- Decreased transport of urea from intracellular to extra-
cellular spaces would increase the apparent volume ofables as dependent variables. Of note, the average weight
in one of the centers (VUMC) was statistically signifi- distribution of urea. To date, the functions of urea trans-
porters in critically ill patients with acute renal failurecantly higher (92.7 vs. 78.3 kg, P  0.05). Since weight is
the most important determinant of volume of distribu- have not been examined.
Patients who develop acute renal failure, especiallytion and TBW, this resulted in statistically significant dif-
ferences between centers for all study variables. In addi- when critically ill with multi-organ dysfunction, are likely
to develop derangements in total body water [25]. Thetion, male patients had statistically significantly higher
“standard operating procedure” in most intensive caredpVurea and TBW by BIA and Hume-Weyer formulae.
units is to vigorously hydrate patients developing sepsisRace, age and status at the end of the study (dead vs.
and multi-organ system dysfunction in an effort to pre-alive) did not have any correlation with TBW and Vurea
vent tissue dehydration and development of ARF [26].determinations. TBW determined by BIA but not other
Such patients often develop decreased plasma oncoticmethods differed between African American and Cauca-
pressure, as well as increased capillary permeability, bothsian patients.
leading to alterations in the relationship of intravascular
to extracellular water. Furthermore, in critically ill pa-
DISCUSSION tients, “cellular dehydration” may occur with resulting
This study examined the relationship between readily cell shrinkage, thereby altering the relationship between
obtainable clinical estimates of Vurea and total body water extracellular and intracellular water stores [27]. Under
in a cohort of patients receiving renal replacement ther- these circumstances, TBW may no longer serve as an
apy for acute renal failure. While studies in the 1950s effective surrogate for somatic protein stores and body
and 60s examined total body water using muscle biopsy cell mass.
techniques, to our knowledge, this is the first study that In the light of the above discussion, an attractive but
systematically examines this relationship in patients dia- speculative hypothesis to explain the observed difference
lyzed for acute renal failure. The striking finding of this in TBW and Vurea is that critically ill patients with acute
study is that all methods of measuring Vurea define a larger renal failure may develop progressive cellular dehydra-
volume of distribution than estimates of total body water. tion, thereby altering the relationship between intracel-
In physiological states, it is generally assumed that at lular water and Vurea. The cellular hydration state is gov-
equilibrium, Vurea is equal to total body water. As a low erned primarily by the activity of ion and substrate
molecular weight, relatively non-polar compound, urea is transport systems in the plasma membrane. Haussinger
assumed to move readily between intracellular and extra- and colleagues have demonstrated that a variety of hor-
cellular spaces to achieve equilibration. Coefficients of mones, substrates and oxidative stress (all of which are
urea diffusion have been calculated in chronic hemodi- likely operative in patients with ARF) can change cellu-
alysis patients and are approximately 450 mL/min, sug- lar hydration state quickly. These investigators have pos-
gesting it is higher than the most common in-vivo dialyzer tulated that cellular dehydration may be an important
clearance currently available [24]. Although compartmen- determinant of protein catabolism [27]. Thus, it is con-
talization of urea clearly can occur, equilibration gener- ceivable that in critically ill patients with acute renal
ally occurs rapidly, even in the setting of high efficiency failure a positive feedback loop is operative where cellu-
dialysis for patients with chronic renal failure. lar dehydration leads to increased urea generation, which
may lead to further cellular dehydration. Using bothA possible explanation for the discrepancy in measure-
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bioelectrical impedance analysis and radioisotope dilu- formulae of either Vurea or total body water have been
thoroughly validated in the acute renal failure patienttion studies, Finn et al have demonstrated that intracel-
population. Thus, for example, although the relationshiplular water decreases by 15 to 20 percent in critically ill
between single pool and both double pool and equili-patients with either blunt trauma or sepsis [28]. A 20 per-
brated Kt/V appear to be similar in patients with acutecent decrease in intracellular water without a correspond-
renal failure to patients with chronic renal failure, formaling decrease in intracellular urea (perhaps because of in-
mass balance studies of urea kinetics in patients withcreased generation rate) would largely explain the discrep-
acute renal failure or independent measurements of ureaancy between Vurea and TBW in our patient population.
and water volume of distributions to validate these equa-In this study, Vurea, determined by single pool urea
tions have not been performed. Such an approach wouldkinetics, was 11% lower than Vurea determined by equili-
require direct dialysate quantification of urea removalbrated urea kinetics and 16% lower than Vurea determined
in critically ill patients, which is logistically difficult. Simi-by double pool urea kinetics. This is not surprising, as
larly, in the absence of a “gold standard assay” to deter-double pool or equilibrated Kt/V is generally lower than
mine total body water, caution must be exercised insingle pool Kt/V. Of note, estimates of Vurea obtained by
estimating total body water either from anthropometricdouble pool and equilibrated urea kinetics were highly
formula or via bioelectrical impedance analysis. There-similar. These results are similar to results obtained in
fore, the results of the present study, particularly as theypatients with ESRD on chronic maintenance hemodialy-
suggest the need to change our thinking about the rela-sis and suggest that the equilibrated Kt/V formula may
tionship of urea volume to body water space in acutehave practical utility as well in patients with acute renal
renal failure patients, should be viewed as tentative untilfailure. However, full validation of the accuracy of for-
confirmed by “gold standard” studies. Nonetheless, de-
mulae for eKt/V in patients with acute renal failure will spite the lack of such reference assays in this study, the
require formal mass balance urea studies. striking finding that all clinically available methods of
We also used five readily available clinical methods determining Vurea result in a larger body space than allto estimate total body water, which have been used in clinically available methods describing TBW support the
different patient populations, including chronic hemodi- provisional conclusion that in ARF, urea volume of dis-
alysis patients. Of note, anthropometric formulae that tribution exceeds total body water.
are based on age, sex, height and weight (Watson, Hume- In summary, we have measured both Vurea and TBW
Weyer and Chertow) significantly underestimated total in a cohort of patients with acute renal failure receiving
body water when measured by either bioelectrical imped- intermittent hemodialysis. Measurements of Vurea are
ance analysis or based on a percentage of body weight. consistently larger than TBW, suggesting that patients
These results were similar to the findings of Chertow et with acute renal failure may not achieve complete intra-
al in chronic hemodialysis patients and Dahl et al in cellular and extracellular urea equilibration and/or may
peritoneal dialysis patients [29, 30]. The observation that be prone to develop intracellular dehydration. In terms
the Watson and Hume-Weyer formulae tend to underes- of useful guidelines to prescribe a specific dose of dialysis
timate TBW is not surprising given that these formulae in patients with acute renal failure, estimates of TBW
were originally derived from healthy volunteers who did should be revised considerably before being be used as
not have conditions that may have affected their state a surrogate for Vurea in determining dialysis adequacy.
of hydration. Consistently, the formulae by Chertow,
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APPENDIX: EQUATIONS USED IN THIS STUDYachievement of estimated dry weight in patients with
acute renal failure. Watson
It should be emphasized that a major limitation of the Male: TBW  2.447  (0.09156 * age)  (0.1074 * height)  (0.3362
* weight)present study is that none of these clinically available
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renal failure: a prospective randomised trial. Lancet 356:26–30, 2000(male * weight)  0.00104135 * (age * weight)  0.00186104 * (height
10. Clark WR, Murphy MH, Alaka KJ, et al: Urea kinetics during* weight)
continuous hemofiltration. ASAIO 38:M664–M667, 1992
Physiologic 11. Clark WR, Mueller BA, Alaka KJ, Macias WL: A comparison
of metabolic control by continuous and intermittent therapies in
TBW  pre-treatment weight  0.6 (males) or 0.55 (female) acute renal failure. J Am Soc Nephrol 4:1413–1420, 1994
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(spKt/V) 85–90, 1994
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umes. Metabolism 10:447–467, 1956
16. Graham JA, Paton AM, Linton AL: Body water and electro-(3) Quantification of Dose:
lyte composition in acute renal failure. Can Med Assoc J 104:1000–
(a) Prescribed Kt/V [(in vitro urea clearance) (prescribed time)]/ 1003, 1971
pre-TBW 17. Swan RC, Merrill JP: The clinical course of acute renal failure.
Medicine 32:215, 1953(b) Predicted Kt/V  (Dialyzer Urea Clearances at 180 min  t)/
18. Hamburger J: Electrolyte disturbances in acute uremia. Clin Chempost-TBW
3:332–343, 1957
(c) Delivered Kt/V 19. Daugirdas JT: Second generation logarithmic estimates of single-
pool variable volume Kt/V: An analysis of error. J Am Soc Nephrol
(i) Single-Pool Kt/V  ln[(R1  (0.008  t)]  [4  (3.5  4:1205–1213, 1993
R1)]  UF/Post-weight 20. Chertow GM, Lazarus JM, Lew NL, et al: Development of a
population-specific regression equation to estimate total body wa-(ii) Equilibrated Kt/V  spKt/V  (0.47  spK/V)/t  0.02
ter in hemodialysis patients. Kidney Int 51:1578–1582, 1997
(iii) Double-Pool Kt/V  ln[(R2  (0.008  t)]  [4  (3.5  21. Kaminsky LA, Whaley MH: Differences in estimates of percent
R2)]  UF/Post-weight body fat using bioelectrical impedance. J Sports Med Phys Fitness
33:172–177, 1993
(4) Urea Nitrogen Appearance: 22. Kushner RF, Schoeller DA: Estimation of total body water by
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